DK0880971T3 - Markofagstimulerende protein til behandling af sygdomme i centralnervesystemet - Google Patents

Markofagstimulerende protein til behandling af sygdomme i centralnervesystemet

Info

Publication number
DK0880971T3
DK0880971T3 DK98109508T DK98109508T DK0880971T3 DK 0880971 T3 DK0880971 T3 DK 0880971T3 DK 98109508 T DK98109508 T DK 98109508T DK 98109508 T DK98109508 T DK 98109508T DK 0880971 T3 DK0880971 T3 DK 0880971T3
Authority
DK
Denmark
Prior art keywords
treatment
nervous system
central nervous
system disorders
protein
Prior art date
Application number
DK98109508T
Other languages
English (en)
Inventor
Paolo Comoglio
Alessandro Vercelli
Francesco Galimi
Gianfranco Caselli
Maria Cristina Stella
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Application granted granted Critical
Publication of DK0880971T3 publication Critical patent/DK0880971T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98109508T 1997-05-28 1998-05-26 Markofagstimulerende protein til behandling af sygdomme i centralnervesystemet DK0880971T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001247A IT1292017B1 (it) 1997-05-28 1997-05-28 Composizioni farmaceutiche contenenti la proteina stimolante i macrofagi per il trattamento di patologie del sistema nervoso

Publications (1)

Publication Number Publication Date
DK0880971T3 true DK0880971T3 (da) 2003-02-24

Family

ID=11377233

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98109508T DK0880971T3 (da) 1997-05-28 1998-05-26 Markofagstimulerende protein til behandling af sygdomme i centralnervesystemet

Country Status (8)

Country Link
US (1) US6030949A (da)
EP (1) EP0880971B1 (da)
AT (1) ATE226445T1 (da)
DE (1) DE69808839T2 (da)
DK (1) DK0880971T3 (da)
ES (1) ES2185083T3 (da)
IT (1) IT1292017B1 (da)
PT (1) PT880971E (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002258798A1 (en) * 2001-04-13 2002-10-28 Children's Hospital Medical Center Methods for the treatment of hepatic disorders
EP1545608A4 (en) 2002-06-28 2006-09-13 Centocor Inc CH1-DELETED MAMMED MUICETIC BODIES, COMPOSITIONS, METHODS AND APPLICATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5696086A (en) * 1994-11-03 1997-12-09 Genentech, Inc. Methods and kits using macrophage stimulating protein
JPH093099A (ja) * 1995-06-20 1997-01-07 Toyobo Co Ltd マクロファージ刺激蛋白質改変体およびその製造法

Also Published As

Publication number Publication date
ITMI971247A1 (it) 1998-11-28
EP0880971A3 (en) 2000-02-02
EP0880971B1 (en) 2002-10-23
ES2185083T3 (es) 2003-04-16
DE69808839D1 (de) 2002-11-28
IT1292017B1 (it) 1999-01-25
US6030949A (en) 2000-02-29
DE69808839T2 (de) 2003-09-18
EP0880971A2 (en) 1998-12-02
ATE226445T1 (de) 2002-11-15
ITMI971247A0 (da) 1997-05-28
PT880971E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
NO963239D0 (no) Klorpyrimid-mellomprodukter
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
DK1382348T3 (da) Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom
DK2052714T3 (da) Topisk gel-fremføringssystem til behandling af hudlidelser
DE69830369D1 (de) Wegwerfbare, zahnärztliche Auftragevorrichtung
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK114997A (da) Mundhygejnepræparat til behandling af halitosis
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
FI952169A0 (fi) Stabiili valmiste veren koagulaatiohäiriöiden hoitamiseksi
DK0458699T3 (da) Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris
DE69738613D1 (de) Prävention und behandlung von skeletterkrankungen mit ep2 subtyp selektiven prostaglandin e2 agonisten
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ATE235245T1 (de) Pharmaceutische komposition
DE3879535D1 (da)
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DK0880971T3 (da) Markofagstimulerende protein til behandling af sygdomme i centralnervesystemet
DK671087D0 (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
ITMI911578A1 (it) Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
DK0972521T3 (da) Farmaceutisk præparat, der indeholder interferon-gamma-stimulatorer
ATE57526T1 (de) P-acylaminobenzamide.
DK0900078T3 (da) Anvendelse af benzonaphthalenderivater til fremstilling af lægemidler til behandling af sygdomme i nervesystemet